FAZM was confirmed as 65.1% early apoptotic cells, 12.5% apoptotic cells, and 2.2% necrotic cells, showing a highly significant level of enhanced anticancer activity. 3.11.
← all excerpts
Folic Acid-Functionalized MWCNT-Conjugated Zirconium Oxide Nanoparticles for Targeted Cancer Cell Delivery of Astaxanthin.
1
—
—